EUVIMEDEUVIMED entdecken
Crossref

Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington’s disease

Edoardo Nicolò Aiello, Federica Solca, Silvia Torre, Annalisa Lafronza, Alessio Maranzano, Ruggero Bonetti, Francesco Scheveger, Sabrina Maffi, Consuelo Ceccarelli, Marta Scocchia, Melissa Casella, Federico Verde und 6 weitere

Neurological Sciences · 2024-03 · 45 (3) · 1079-1086

DOI: 10.1007/s10072-023-07070-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, online erschienen am 28.09.2023. Verfasst von Edoardo Nicolò Aiello und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy. Hauptthemen laut MEDLINE: Huntington Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This study is aimed at assessing the clinimetric properties and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in patients with Huntington's disease (HD). METHODS: N = 39 motor-manifest HD patients, N = 74 Parkinson's disease (PD) patients and N = 92 matched HCs were administered the MoCA. HD patients further underwent the Unified Huntington's Disease Rating Scale (UHDRS), self-report questionnaires for anxiety and depression and a battery of first- and second-level cognitive tests. Construct validity was tested against cognitive and behavioural/psychiatric measures, whereas ecological validity against motor-functional subscales of the UHDRS. Sensitivity to disease severity was tested, via a logistic regression, by exploring whether the MoCA discriminated between patients in Shoulson-Fahn stage ≤ 2 vs. > 2. The same analysis was employed to test its ability to discriminate HD patients from HCs and PD patients. RESULTS: The MoCA converged towards cognitive and behavioural measures but diverged from psychiatric ones, being also associated with motor/functional measures from the UHDRS. In identifying patients with cognitive impairment, adjusted MoCA scores were highly accurate (AUC = .92), yielding optimal diagnostics at the cut-off of < 19.945 (J = .78). The MoCA was able to discriminate patients in the middle-to-advanced from those in the early-to-middle stages of the disease (p = .037), as well as to differentiate HD patients from both HCs (p < .001) and PD patients (p < .001). CONCLUSIONS: The MoCA is a valid, diagnostically sound and feasible cognitive screener in motor-manifest HD patients, whose adoption is thus encouraged in clinical practice and research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseCognitive DysfunctionHumansFeasibility StudiesMental Status and Dementia TestsNeuropsychological TestsItaly

Stichwörter der Autor:innen

Cognitive screeningDiagnosticsDysexecutiveHuntington’s diseaseMontreal Cognitive AssessmentPsychometrics

Autor:innen und Institutionen

  • Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Neurology Residency Program, Università degli Studi di Milano, Milan, Italy.
  • Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza Research Hospital, San Giovanni Rotondo, Italy.
  • Italian League for Research On Huntington (LIRH) Foundation, Rome, Italy.
  • Department of Pathophysiology and Transplantation, "Dino Ferrari Center", Università degli Studi di Milano, Milan, Italy.
  • Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy. b.poletti@auxologico.it.

Förderung

  • Ministero della Salute

Zitieren

APA

Aiello, E. N., Solca, F., Torre, S., Lafronza, A., Maranzano, A., Bonetti, R., Scheveger, F., Maffi, S., Ceccarelli, C., Scocchia, M., Casella, M., Verde, F., Migliore, S., Silani, V., Ticozzi, N., Squitieri, F., Ciammola, A., & Poletti, B. (2024). Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington’s disease. Neurological Sciences, 45(3), 1079-1086. https://doi.org/10.1007/s10072-023-07070-7

Vancouver

Aiello EN, Solca F, Torre S, Lafronza A, Maranzano A, Bonetti R, et al. Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington’s disease. Neurological Sciences. 2024;45(3):1079-1086. doi:10.1007/s10072-023-07070-7

BibTeX
@article{Aiello2024,
  author = {Aiello, Edoardo Nicolò and Solca, Federica and Torre, Silvia and Lafronza, Annalisa and Maranzano, Alessio and Bonetti, Ruggero and Scheveger, Francesco and Maffi, Sabrina and Ceccarelli, Consuelo and Scocchia, Marta and Casella, Melissa and Verde, Federico and Migliore, Simone and Silani, Vincenzo and Ticozzi, Nicola and Squitieri, Ferdinando and Ciammola, Andrea and Poletti, Barbara},
  title = {Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington’s disease},
  journal = {Neurological Sciences},
  year = {2024},
  volume = {45},
  number = {3},
  pages = {1079--1086},
  doi = {10.1007/s10072-023-07070-7}
}
Kostenlos starten →